Delivery Order SPE2DB22D9239-SPE2DB25FDL55
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $48,718.74 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,718.68 for 50 mg vials of Adcetris, an oncology treatment used in cancer therapy. The award, issued on September 16, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents a delivery order under the company's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 29, 2025, for the supply of Adcetris 50 mg vials, an oncology medication. The contract carries a ceiling value of approximately $64,054 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was funded by the Defense Logistics Agency's Medical Supply Chain division and includes...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,119.78 by the Defense Logistics Agency (DLA) for the supply of 50 mg vials of Adcetris, an oncology medication. This delivery order, issued under firm fixed-price terms, is expected to be completed by October 7, 2025, with the award date of September 16, 2025. The contract carries no set-aside designation, allowing DMS...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $68,915.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription...
- The Defense Logistics Agency awarded a $64,958.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Adcetris (brentuximab vedotin) 50 mg vials. The contract, effective May 30, 2025, with ultimate completion by June 23, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $44,728.26, covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 30, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $45,943.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564357709 ADCETRIS 50 MG VIALS. This Delivery Order contract is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC...
- This firm fixed-price delivery order worth $133,673.60 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The order was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 Indefinite Delivery Contract (IDC) valid through November 2026. The order is for 4559428135 ADCETRIS 50 MG VIALS, a specialized oncology medication. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL55Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $97,437.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order carries no set-aside designation, allowing the vendor to compete directly in the federal marketplace despite its small business status. This award falls under DMS Pharmaceutical Group's significant $500 million IDC with the Defense Logistics Agency's SPE2DB program, which extends through November 2026 and authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Adcetris, a specialty oncology medication, aligns with the vendor's established portfolio of branded and generic prescription drugs, biologics, and specialized pharmaceutical products delivered to military health facilities. DMS Pharmaceutical Group has demonstrated consistent performance as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business designation and comprehensive product offerings to support DoD medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.4k | 9/4/25 |